<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MSJ</journal-id>
<journal-id journal-id-type="hwp">spmsj</journal-id>
<journal-id journal-id-type="nlm-ta">Mult Scler</journal-id>
<journal-title>Multiple Sclerosis Journal</journal-title>
<issn pub-type="ppub">1352-4585</issn>
<issn pub-type="epub">1477-0970</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1352458511411229</article-id>
<article-id pub-id-type="publisher-id">10.1177_1352458511411229</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letter to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Veauthier</surname><given-names>Christian</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511411229">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Paul</surname><given-names>Friedemann</given-names></name>
<xref ref-type="aff" rid="aff2-1352458511411229">2</xref>
<xref ref-type="aff" rid="aff3-1352458511411229">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-1352458511411229"><label>1</label>Hanse-Klinikum, Department of Neurology, Stralsund, Germany.</aff>
<aff id="aff2-1352458511411229"><label>2</label>NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Charité University Medicine Berlin and Max Delbrueck Center for Molecular Medicine, Berlin, Germany</aff>
<aff id="aff3-1352458511411229"><label>3</label>Experimental and Clinical Multiple Sclerosis Research Center, Charité University Medicine Berlin, Berlin, Germany</aff>
<author-notes>
<corresp id="corresp1-1352458511411229">Christian Veauthier, MD; Hanse-Klinikum, Department of Neurology, Große Parower Strasse 47-53, 18435 Stralsund, Germany Email: <email>cveauthier@web.de</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>18</volume>
<issue>2</issue>
<fpage>248</fpage>
<lpage>249</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Recently we published the results of a previous study, the first cross-sectional polysomnographic investigation with consecutive unselected MS patients<sup><xref ref-type="bibr" rid="bibr1-1352458511411229">1</xref></sup> in this journal. We found a significant association between relevant sleep disorders according to the International Classification of Sleep Disorders second edition<sup><xref ref-type="bibr" rid="bibr2-1352458511411229">2</xref></sup> and fatigue, measured with the Modified Fatigue Impact Scale (MFIS) and the Fatigue Severity Scale (FSS). However, there was no relationship between sleep disorders and the values in the Epworth Sleepiness Scale (ESS).</p>
<p>In order to find a screening instrument for sleep disorders in MS-related fatigue we investigated retrospectively the usefulness of the Pittsburgh Sleep Quality Index (PSQI) and the MFIS, both applied in our previously reported polysomnographic investigation,<sup><xref ref-type="bibr" rid="bibr1-1352458511411229">1</xref></sup> to predict the presence of a sleep disorder.</p>
<p>In our recent study 66 MS patients (21 male, 45 female, mean age 43.2 years, standard deviation 10.0, range 20–66; mean disease duration 137.4 months, standard deviation 108.2, range 13–469; median Expanded Disability Status Scale [EDSS] 2.0, range 0–7.5)<sup><xref ref-type="bibr" rid="bibr1-1352458511411229">1</xref></sup> were examined with two overnight polysomnographies and completed, amongst other measures, the MFIS and PSQI. In our previously published study we did not calculate the values of the PSQI. Now we report for the first time the findings of a retrospective analysis of these PSQI values and we compare them with the polysomnography. A receiver operating characteristic (ROC) analysis was performed (SPSS 13, SPSS Inc., Chicago, IL, USA).</p>
<p>A global PSQI score greater than 5 yielded a diagnostic sensitivity of 75% and 64.7% specificity (positive predictive value 85.7%; negative predictive value 47.8%). In line with the original paper from Buysse et al.,<sup><xref ref-type="bibr" rid="bibr3-1352458511411229">3</xref></sup> a threshold value of &gt;5 in the PSQI appeared to be the best cut-off-point to predict sleep disturbances. A MFIS score of &gt;34 yielded a diagnostic sensitivity of 71.4% and a specificity of 82.4% for predicting sleep disorders as detected by polysomnography (positive predictive value 92.1%; negative predictive value 50%).</p>
<p>By jointly applying the MFIS cut-off of 34 and the PSQI cut-off of 5 (either MFIS &gt;34 or PSQI &gt;5), a higher sensitivity of 89.8% was achieved (specificity 58.8%, positive predictive value 86.3%, negative predictive value 66.7%).</p>
<p>Our data show that the combination of two self-rating questionnaires which can easily be filled out within a few minutes are a good screening instrument for sleep disorders in MS-related fatigue and can predict sleep disorders with a good sensitivity, with a good positive predictive value and with sufficient specificity.</p>
<p>The treatment of MS-related fatigue remains difficult, because no specific drug therapy exists.<sup><xref ref-type="bibr" rid="bibr4-1352458511411229">4</xref></sup> As there are, in contrast to fatigue, specific and efficacious treatment options for the majority of sleep disorders, an early diagnosis of these conditions is warranted. Therefore, in all fatigued MS patients, a careful medical history which may point to sleep disturbances should be performed; of course symptomatic causes such as hypothyroidism and anemia should also be excluded. In the case of insomnia, complaints indicating restless legs syndrome, nocturia and pain, these sleep disorders should already be treated without polysomnographic investigations. However, it is MS patients in particular who may be denied access to sleep diagnostic procedures, as the treating physician may attribute daytime tiredness to MS-related fatigue and thus regard a polysomnography as unnecessary. In this context, it is important to point out that periodic limb movement disorders, sleep-related breathing disorders and some other dyssomnias are in many cases not recognized by the patients themselves or their bed partners. Therefore, in order not to misdiagnose sleep disorders, all fatigued MS patients with MFIS values greater than 34 or PSQI values greater than 5 should be referred to a sleep specialist and undergo subsequent polysomnography.</p>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>This work was supported by the German Research Foundation (DFG Exc 257 to FP).</p>
</fn>
<fn fn-type="conflict">
<p>The authors declare no conflicts of interest in preparing this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1352458511411229">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Veauthier</surname><given-names>C</given-names></name>
<name><surname>Radbruch</surname><given-names>H</given-names></name>
<name><surname>Gaede</surname><given-names>G</given-names></name>
<name><surname>Pfueller</surname><given-names>CF</given-names></name>
<name><surname>Dörr</surname><given-names>J</given-names></name>
<name><surname>Bellmann-Strobl</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study</article-title>. <source>Mult Scler</source> <year>2011</year>; <comment>in press</comment>.</citation>
</ref>
<ref id="bibr2-1352458511411229">
<label>2.</label>
<citation citation-type="book">
<collab>American Academy of Sleep Medicine (AASM)</collab>. <source>International Classification of Sleep Disorders</source>, <edition>2nd ed</edition>. <publisher-loc>Westchester, IL</publisher-loc>: <publisher-name>AASM</publisher-name>, <year>2005</year>.</citation>
</ref>
<ref id="bibr3-1352458511411229">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buysse</surname><given-names>DJ</given-names></name>
<name><surname>Reynolds</surname><given-names>CF</given-names></name>
<name><surname>Monk</surname><given-names>TH</given-names></name>
<name><surname>Berman</surname><given-names>SR</given-names></name>
<name><surname>Kupfer</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research</article-title>. <source>Psychiatry Res</source> <year>1989</year>; <volume>28</volume>: <fpage>193</fpage>–<lpage>213</lpage>.</citation>
</ref>
<ref id="bibr4-1352458511411229">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stankoff</surname><given-names>B</given-names></name>
<name><surname>Waubant</surname><given-names>E</given-names></name>
<name><surname>Confavreux</surname><given-names>C</given-names></name>
<name><surname>Edan</surname><given-names>G</given-names></name>
<name><surname>Debouverie</surname><given-names>M</given-names></name>
<name><surname>Rumbach</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study</article-title>. <source>J Neurol</source> <year>2005</year>; <volume>64</volume>: <fpage>1139</fpage>–<lpage>1143</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>